Complication | Evidence | PMID |
Nephropathy | 1. The amount of UCP2 protein expression was up-regulated in the kidney from DN mice and genipin treatment inhibited this up-regulation both in vivo and in vitro. | 22848482 |
Retinopathy | 1. It was indicated that UCP2 may be implicated in the pathogenesis of type 2 DM and DR in Chinese population. | 25396419 |
Atherosclerosis | 1. type 2 diabetes is associated with increased risk of cardiovascular disease and atherosclerosis where an increased expression of UCP2 appears to be beneficial. | 16487034 |
Neuropathy | 1. UCP2 promoter gene polymorphism -866 G/A was significantly associated with nerve conduction slowing and vasomotor sympathetic functions. These findings suggest that the higher UCP2 activity related to the A allele has an energy-depleting effect on peripheral nerve function in type 2 diabetic patients. | 16567833 |
Insulin resistance and inflammation | 1.Silencing of UCP2 mRNA in FABP4/aP2-deficient macrophages negated the protective effect of FABP loss and increased ER stress in response to palmitate or lipopolysaccharide (LPS). | 25582199 |